Genetic Analysis of ME/CFS

About PrecisionLife

Founded in 2014 and headquartered in Oxford, PrecisionLife is a private AI-driven precision medicine company targeting complex chronic diseases. Its core technology uses combinatorial analytics on genetic and multimodal patient data to identify novel disease mechanisms and patient subgroups, enabling the discovery of biomarkers for risk prediction and treatment response. The company operates a platform business model, partnering with biobanks, pharma, and healthcare systems to develop diagnostic tools (termed 'Mechanostics') and support therapeutic development, positioning itself as a key enabler in the shift towards personalized, preventative healthcare.

Therapeutic Areas